These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076 [TBL] [Abstract][Full Text] [Related]
3. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. Soll AH JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244 [TBL] [Abstract][Full Text] [Related]
4. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication]. Ballesteros-Amozurrutia MA Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621 [TBL] [Abstract][Full Text] [Related]
5. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A; Remacha B; Sáinz R; Hirschowitz BI Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760 [TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993 [TBL] [Abstract][Full Text] [Related]
8. Quality of healing in peptic ulcer disease--are H2 receptor antagonists all we need? Korman MG Gastroenterol Jpn; 1993 May; 28 Suppl 5():168-71. PubMed ID: 8103021 [TBL] [Abstract][Full Text] [Related]
9. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802 [TBL] [Abstract][Full Text] [Related]
10. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection and the use of NSAIDs. Bazzoli F; De Luca L; Graham DY Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040 [TBL] [Abstract][Full Text] [Related]
12. Critical issues in the pathophysiology and management of peptic ulcer disease. Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166 [TBL] [Abstract][Full Text] [Related]
13. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
15. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Hunt RH; Bazzoli F Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261 [TBL] [Abstract][Full Text] [Related]
17. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
18. Peptic ulcer and dyspepsia. Soll AH Clin Cornerstone; 1999; 1(5):29-41. PubMed ID: 10682180 [TBL] [Abstract][Full Text] [Related]
19. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Labenz J; Börsch G Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]